🇺🇸 patients with sunitinib or pazopanib in United States

patients with sunitinib or pazopanib (patients with sunitinib or pazopanib) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

patients with sunitinib or pazopanib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is patients with sunitinib or pazopanib approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for patients with sunitinib or pazopanib in United States?

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the originator. The local marketing authorisation holder may differ — check the official source linked above.